BR112022012118A2 - Kit para preparar uma composição de nanopartículas - Google Patents

Kit para preparar uma composição de nanopartículas

Info

Publication number
BR112022012118A2
BR112022012118A2 BR112022012118A BR112022012118A BR112022012118A2 BR 112022012118 A2 BR112022012118 A2 BR 112022012118A2 BR 112022012118 A BR112022012118 A BR 112022012118A BR 112022012118 A BR112022012118 A BR 112022012118A BR 112022012118 A2 BR112022012118 A2 BR 112022012118A2
Authority
BR
Brazil
Prior art keywords
kit
prepare
nanoparticle
composition
drug
Prior art date
Application number
BR112022012118A
Other languages
English (en)
Inventor
Jin Lee So
Hoon Kim Sang
Young Park Joon
Yeong Nam Hye
Yeon Son Ji
Original Assignee
Samyang Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Holdings Corp filed Critical Samyang Holdings Corp
Publication of BR112022012118A2 publication Critical patent/BR112022012118A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

KIT PARA PREPARAR UMA COMPOSIÇÃO DE NANOPARTÍCULAS. A presente invenção refere-se a um kit para preparar uma composição de nanopartículas para entrega de fármacos e, mais especificamente, a um kit para preparar uma composição de nanopartículas para entrega de fármacos que é projetado para formar facilmente uma nanopartícula na qual um fármaco é encapsulado simplesmente pela mistura de um copolímero em bloco anfifílico, um composto catiônico, um sal de ácido polilático e o fármaco, que são os componentes do kit.
BR112022012118A 2019-12-20 2020-12-16 Kit para preparar uma composição de nanopartículas BR112022012118A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20190171528 2019-12-20
PCT/KR2020/018480 WO2021125805A1 (ko) 2019-12-20 2020-12-16 폴리락트산염을 포함하는 약물전달용 나노입자 조성물 제조용 키트

Publications (1)

Publication Number Publication Date
BR112022012118A2 true BR112022012118A2 (pt) 2022-08-30

Family

ID=76477867

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022012118A BR112022012118A2 (pt) 2019-12-20 2020-12-16 Kit para preparar uma composição de nanopartículas

Country Status (9)

Country Link
US (1) US20230039124A1 (pt)
EP (1) EP4079298A4 (pt)
JP (1) JP2023508313A (pt)
KR (1) KR102650691B1 (pt)
CN (1) CN115135310A (pt)
AU (1) AU2020407348A1 (pt)
BR (1) BR112022012118A2 (pt)
CA (1) CA3162374A1 (pt)
WO (1) WO2021125805A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230072453A (ko) 2021-11-17 2023-05-24 주식회사 엘지생활건강 구형 물질을 포함하는 두피 또는 모발용 조성물
WO2024053862A1 (ko) * 2022-09-08 2024-03-14 주식회사 삼양홀딩스 약물 함유 나노입자 제조용 키트 및 약물전달용 나노입자 조성물
KR20240066080A (ko) * 2022-11-01 2024-05-14 주식회사 삼양홀딩스 아마이드 및 에스터 작용기를 갖는 지질 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05111524A (ja) * 1991-10-23 1993-05-07 Maeda Sangyo Kk 医療用キツト製品
CA2370690A1 (en) 1999-04-20 2000-10-26 The University Of British Columbia Cationic peg-lipids and methods of use
KR100502840B1 (ko) * 2002-09-04 2005-07-21 학교법인 포항공과대학교 약물 담지능력이 우수한 블록 공중합체 미셀 조성물
EP3357491B1 (en) * 2015-09-15 2021-06-02 Samyang Biopharmaceuticals Corporation Pharmaceutical composition for delivering an anionic drug
CA3063989A1 (en) * 2017-05-30 2018-12-06 Glaxosmithkline Biologicals Sa Methods for manufacturing a liposome encapsulated rna
KR20190127277A (ko) * 2018-05-04 2019-11-13 주식회사 삼양바이오팜 mRNA 전달용 고분자 나노입자 조성물 및 그 제조방법

Also Published As

Publication number Publication date
CN115135310A (zh) 2022-09-30
EP4079298A1 (en) 2022-10-26
WO2021125805A1 (ko) 2021-06-24
KR20210081256A (ko) 2021-07-01
AU2020407348A1 (en) 2022-07-14
EP4079298A4 (en) 2024-01-17
US20230039124A1 (en) 2023-02-09
CA3162374A1 (en) 2021-06-24
KR102650691B1 (ko) 2024-03-25
JP2023508313A (ja) 2023-03-02

Similar Documents

Publication Publication Date Title
BR112022012118A2 (pt) Kit para preparar uma composição de nanopartículas
BR112014011841A2 (pt) material de entrega de fármacos hidrofóbicos, método para a produção do mesmo e métodos para a entrega de uma composição de entrega de fármacos
UY37617A (es) Moduladores de la proteína reguladora de la conductancia transmembrana en fibrosis quística y métodos de empleo
BR112015022047A8 (pt) uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina
BR112015021970A2 (pt) composições à base de nanopartículas
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
BR112014029754B1 (pt) soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição
BR112017001968A2 (pt) embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
BR112015015137A2 (pt) estrutura à base de polietileno
BR112015004871A2 (pt) composição para formação de revestimento sólido e junta tubular rosqueada
BR112014022780A8 (pt) composto modulador de receptor de fígado x, composição farmacêutica que o compreende e seu uso
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
BR112013022213A2 (pt) administração parenteral de tapentadol
BR112017011623A2 (pt) composições farmacêuticas e processo para a preparação de uma composição
BR112017022846A2 (pt) combinação de dose fixa inviolável que proporciona rápida liberação de dois fármacos de partículas diferentes
BR112017000312A2 (pt) sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal
BR112018012952A2 (pt) composições para higiene pessoal
BR112018014123A2 (pt) formulação farmacêutica aquosa estável.
BR112018004719A2 (pt) composto de fluoroindola, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor muscarínico m1 e uso do composto
BR112014014038A2 (pt) composição para inibição do pós-cirúrgico de catarata e método para preparação da mesma
BR112017011256A2 (pt) métodos de preparação de concentrado em suspensão (sc) de pesticida, concentrado em suspensão (sc) de pesticida, e método de semeadura de campo
CL2016003155A1 (es) Composiciones de cuidado bucal
BR112017009811A2 (pt) composição e método para a modelagem de cabelo
BR112015025058A2 (pt) composição farmacêutica capaz de controlar facilmente o padrão de dissolução de lacosamida ou de um sal farmaceuticamente aceitável da mesma
BR112015000275A2 (pt) utilização de um extrato de mirta como agente anti-biopelícula face p. acnes